Why CorMedix stock crashed today and is it worth buying on the dip?
(Originally posted on : Invezz )
Investors are bailing on CorMedix (NASDAQ: CRMD) today after the biotech firm guided for up to $320 million in revenue for its fiscal 2026.
The announcement isn’t sitting well with shareholders, primarily because CRMD’s topline was roughly $400 million in the prior year, according to the preliminary full-year financials it posted on Thursday.
Simply put, the NJ-headquartered firm expects its revenue to shrink this year, which seldom bodes well for investors. Following today’s plunge, CorMedix stock is down over 50% from its 52-week high.
CorMedix stock to remain subdued on DefenCath weakness
On July 1st, DefenCath will lose its temporary TDAPA reimbursement status and shift to a notably less favourable post-TDAPA add-on adjustment.
What this means is that dialysis providers will receive lower institutional reimbursement, and CorMedix will face materially reduced net pricing.
This will directly pressure its margins and undermine its near-term revenue visibility.
Note that “DefenCath” was CorMedix’s sole commercial product for a long time – and while the recent Melinta acquisition did expand its portfolio, those new revenue sources aren’t yet material enough to offset the expected weakness in its antimicrobial catheter lock solution.
This makes buying the dip in CRMD stock a rather risky proposition for serious investors.
CRMD shares’ technicals are just as concerning
CorMedix shares remain unattractive despite the sharp pullback, also because the management sees DefenCath sales sliding further to $140 million at the top end of its range in 2027.
Moreover, it’s not just fundamentals – the company’s technicals are just as concerning.
At the time of writing, CRMD is trading decisively below its major moving averages (MAs), indicating bears remain in control across multiple timeframes.
Plus, the biotech stock’s long-term relative strength index (100-day) sits at about “45” currently – which means the broader downtrend isn’t approaching exhaustion either.
Note that insiders have predominantly unloaded CorMedix in the trailing 12 months, reinforcing that those closest to the company believe it was overvalued at north of $10.
Taken together, these insights further strengthen the bear case for CRMD in 2026.
Is it worth investing in CorMedix today?
On Thursday, CorMedix also said its chief executive, Joseph Todisco, is taking over as chairman of the board as well.
This consolidation resides significant power in a single individual, reducing checks and balances that independent board oversight typically provides.
For investors, this dual role can be unsettling – as it heightens governance risk and may complicate accountability.
In the near term, this transition may mean uncertainty around strategic decision‑making, potentially undermining confidence in CRMD shares.
What’s also worth mentioning is that Wall Street had a consensus “buy” rating and $19 price target on CorMedix heading into 2026.
It’s reasonable to assume, however, that following the DefenCath update today, at least some firms will choose to downwardly revise their estimates for CRMD.
Bitcoin 
Ethereum 
Tether 
XRP 
BNB 
Solana 
USDC 
TRON 
Lido Staked Ether 
Dogecoin 
Figure Heloc 
Cardano 
Bitcoin Cash 
Wrapped stETH 
WhiteBIT Coin 
Wrapped Beacon ETH 
Wrapped Bitcoin 
Monero 
Wrapped eETH 
USDS 
Chainlink 
Binance Bridged USDT (BNB Smart Chain) 
LEO Token 
WETH 
Stellar 
Coinbase Wrapped BTC 
Sui 
Ethena USDe 
Zcash 
Litecoin 
Avalanche 
Hyperliquid 
Canton 
Hedera 
Shiba Inu 
USDT0 
World Liberty Financial 
Dai 
sUSDS 
Toncoin 
Cronos 
Ethena Staked USDe 
PayPal USD 
Uniswap 
USD1 
Polkadot 
Mantle 
Rain 
MemeCore 
Bittensor 
Aave 
Bitget Token 
Pepe 
Tether Gold 
OKB 
NEAR Protocol 
Falcon USD 
Jito Staked SOL 
Ethereum Classic 
Binance-Peg WETH 
Ethena 
Pi Network 
PAX Gold 
POL (ex-MATIC) 
BlackRock USD Institutional Digital Liquidity Fund 
Internet Computer 
Aster 
Jupiter Perpetuals Liquidity Provider Token 
HTX DAO 
Binance Staked SOL 
Worldcoin 
Circle USYC 
Global Dollar 
KuCoin 
Pump.fun 
syrupUSDC 
Ripple USD 
Render 
Sky 
Aptos 
Provenance Blockchain 
BFUSD 
Wrapped BNB 
Rocket Pool ETH 
Binance Bridged USDC (BNB Smart Chain) 
Ondo 
Kaspa 
Cosmos Hub 
Gate 
Algorand 
Arbitrum 
Midnight 
Kelp DAO Restaked ETH 
Official Trump 
Quant 
Filecoin 
MYX Finance 
Bridged Wrapped Lido Staked Ether (Scroll) 
VeChain 
Lombard Staked BTC